Thyroid Cancer and MEN2: C Cells, RET and Parathyroid | Part 1 | 頭頸腫瘤 | OET Music

Dr Allison Lu · Pip & Barnaby · Medical English

本頁提供本曲完整英文歌詞與影片搭配的繁中醫學提示。歌詞保留原演唱文字;遇到過度簡化或舊門檻,請搭配下方提示與原始資料閱讀。這是概念學習材料,不替代個別醫療評估。

Lyrics · 完整歌詞

Two principal cellular lineages provide a useful framework for understanding the major thyroid carcinomas:
follicular epithelial cells and parafollicular C cells.
Follicular epithelium gives rise to papillary, follicular and, by dedifferentiation, anaplastic carcinoma.
Parafollicular C cells stand apart and produce medullary carcinoma.
Papillary carcinoma, the commonest, is diagnosed by nuclear features: ground-glass chromatin,
grooves and intranuclear pseudoinclusions,
often with psammoma bodies and a BRAF V600E mutation.
Prominent nucleoli are not among them.
Follicular carcinoma looks identical to adenoma on cytology,
so capsular or vascular invasion on histology, not aspiration, separates the two.
Anaplastic carcinoma presents as a rapidly enlarging hard mass in an older patient
and carries TP53 mutations.

Medullary carcinoma behaves as its lineage predicts.
C cells secrete calcitonin, deposit amyloid in the stroma,
spread mainly through lymphatics and never trap iodine,
so radioiodine is useless and calcitonin with CEA becomes the follow-up marker.
Thyroglobulin serves the follicular-derived tumours instead.
About a quarter of medullary cancers are hereditary,
driven by germline RET mutations.
MEN2A combines medullary carcinoma, phaeochromocytoma and parathyroid hyperplasia; MEN2B combines medullary carcinoma,
phaeochromocytoma and mucosal neuromas with a marfanoid habitus, but spares the parathyroids.

One rule is absolute:
phaeochromocytoma must be excluded or treated before the thyroid is removed,
or catecholamine release under anaesthesia will provoke a hypertensive crisis.

Two principal cellular lineages provide a useful framework for understanding the major thyroid carcinomas:
follicular epithelial cells and parafollicular C cells.


The parathyroids are read along three axes: calcium, phosphate and PTH.
PTH keeps calcium in and drives phosphate out.
Primary hyperparathyroidism, usually a single adenoma, therefore shows high calcium,
low phosphate and high PTH, with a tendency to hyperchloraemic acidosis.
Secondary hyperparathyroidism in chronic kidney disease shows low or normal calcium,
high phosphate and a compensatory high PTH.
When years of stimulation make the glands autonomous,
calcium flips from low to high and tertiary disease has arrived.
Malignancy raises calcium through PTHrP or bone metastases, and PTH is suppressed,
which separates it from every parathyroid cause.
Cinacalcet sensitises the calcium-sensing receptor, so PTH and calcium both fall.

Removing or bruising the parathyroids reverses the equation.
After thyroidectomy, calcium falls while phosphate rises, nerves become hyperexcitable,
and perioral tingling, Chvostek's and Trousseau's signs and carpopedal spasm appear,
sometimes with a prolonged QT interval.
Symptomatic hypocalcaemia receives intravenous calcium gluconate on a monitor,
followed by oral calcium and calcitriol.
Magnesium must be checked, because hypomagnesaemia blocks PTH release.
Laryngospasm and haematoma both threaten the airway.

Two principal cellular lineages provide a useful framework for understanding the major thyroid carcinomas:
follicular epithelial cells and parafollicular C cells.

Medical Notes · 醫學學習提示

  1. 甲狀腺主要癌別,可依兩種細胞譜系理解
  2. 濾泡上皮細胞與濾泡旁 C 細胞,來源不同
  3. 乳突癌、濾泡癌與未分化癌屬濾泡細胞譜系
  4. 髓質癌源自濾泡旁 C 細胞
  5. 乳突癌以核特徵為重點:核染色質透明
  6. 可見核溝與核內偽包涵體,須綜合判讀
  7. 砂粒體與 BRAF V600E 可出現,但不是每例都有
  8. 顯著核仁不是典型核心特徵,不能單憑此排除
  9. 細針細胞學通常無法區分濾泡腺瘤與濾泡癌
  10. 須看包膜或血管侵犯;不能只靠抽吸判定
  11. 快速增大的硬頸部腫塊,須急評估未分化癌與氣道
  12. TP53 異常常見,並非所有病例皆有
  13. 髓質癌的檢查與治療,須依 C 細胞特性
  14. 可分泌降鈣素;腫瘤間質可見類澱粉沉積
  15. 可有淋巴與血行轉移;不具有效攝碘功能
  16. 放射碘不適用;追蹤降鈣素與 CEA
  17. 甲狀腺球蛋白用於分化型癌追蹤,未分化癌未必表現
  18. 約四分之一髓質癌屬遺傳型
  19. 胚系 RET 檢測與遺傳諮詢,協助家族風險評估
  20. MEN2A 可合併髓質癌、嗜鉻細胞瘤與副甲狀腺疾病
  21. MEN2B 常有黏膜神經瘤與類馬凡體態,通常無副甲亢
  22. 髓質癌與 MEN2 的術前評估:勿漏嗜鉻細胞瘤
  23. 若並存嗜鉻細胞瘤,須先控制並處理,再做甲狀腺手術
  24. 麻醉與手術可能誘發兒茶酚胺危象
  25. 用細胞譜系串起甲狀腺癌;圖為正常結構示意
  26. 濾泡細胞與 C 細胞的功能及腫瘤標記不同
  27. 副甲狀腺判讀三軸:血鈣、血磷與 PTH
  28. PTH 促腎臟保鈣與排磷;須合併腎功能理解
  29. 原發性副甲亢常為單一腺瘤;也有正常血鈣型
  30. PTH 升高或不適當正常;低磷與酸中毒非必備
  31. 腎病性次發副甲亢,血鈣可低或正常
  32. 晚期腎病常高磷;早期血磷也可能正常
  33. 長期刺激後,部分腺體逐漸自主分泌
  34. 三發副甲亢常高鈣,須結合病程與治療史判讀
  35. 惡性腫瘤高鈣常抑制 PTH;也有活性維生素 D 機轉
  36. 不能一概區分所有原因;癌症與副甲亢可能並存
  37. Cinacalcet 提高鈣感受器敏感性;須監測低血鈣
  38. 手術移除、缺血或損傷,可造成副甲狀腺低下
  39. 術後 PTH 不足可低鈣高磷,但不是每人都發生
  40. 口周麻、手足痙攣等提示低鈣;體徵不能單獨確診
  41. 低血鈣可能延長 QT,須評估心律風險
  42. 嚴重或有症狀低鈣:監測下靜脈葡萄糖酸鈣
  43. 副甲低下後續常需口服鈣與活性維生素 D
  44. 同步檢查與補正低鎂;急救補鈣不能等待鎂結果
  45. 喉痙攣或術後頸部血腫均可危及氣道,須立即處理
  46. 回顧兩種細胞譜系,連結癌別、標記與治療
  47. 濾泡細胞與 C 細胞;正常示意圖不能用來診斷癌症

References